OnKure Therapeutics develops small molecule drugs that target mutated forms of the PI3K alpha protein in cancer and other diseases. It last closed at $2.70 on Nov 20, down 2.17% on the day. The next earnings report for OKUR is expected around Thu, Mar 11, 2027, after the close. For the quarter ended Sep 2026, OKUR reported EPS of -$0.36 on revenue of $1.5M, with revenue up 87.7% from a year ago. Over its last 8 reports the stock moved an average of 7.5% the session after earnings. Over the last 12 months OKUR insiders bought $0 of stock on the open market and sold $6K, according to SEC Form 4 filings.
AI Auto Pilots
Is OKUR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold OKUR.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on OKURStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
OKUR · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend
The stock sits between its 20 and 50 day averages. It is 34% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 49). The nearest support is the 50 day average at $2.67, and the nearest resistance the swing high (Oct 27) at $2.72.
Short trendBullish
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 10.3%/day
Key levels
$5.3852 week high+99.3%
$3.62200 day average+34.1%
$3.33100 day average+23.3%
$2.78Pivot R1+3.0%
$2.7620 day average+2.2%
$2.73Pivot+1.1%
$2.72Swing high (Oct 27)+0.7%
$2.70Last close
$2.6750 day average−1.1%
$2.65Pivot S1−1.9%
$2.50Swing low (Nov 17)−7.4%
$2.0152 week low−25.6%
Indicators
RSI (14)
48.71
Middle of its range
Neutral
MACD
0.03
Below its signal line
Bearish
Stochastic
35.2
Middle of its range
Neutral
ADX (14)
13.7
No clear trend
Williams %R
-69.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-5.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−5.8%
Change over 10 sessions
Bearish
ATR (14)
$0.28
Typical daily range, 10.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 21.6%/day
Key levels
$5.3852 week high+99.3%
$3.62200 day average+34.1%
$3.33100 day average+23.3%
$2.78Pivot R1+3.0%
$2.7620 day average+2.2%
$2.73Pivot+1.1%
$2.72Swing high (Oct 27)+0.7%
$2.70Last close
$2.6750 day average−1.1%
$2.65Pivot S1−1.9%
$2.50Swing low (Nov 17)−7.4%
$2.0152 week low−25.6%
Indicators
RSI (14)
41.17
Middle of its range
Neutral
MACD
-0.34
Below its signal line
Bearish
Stochastic
29.6
Middle of its range
Neutral
ADX (14)
17.6
No clear trend
Williams %R
-71.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-59.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−12.9%
Change over 10 sessions
Bearish
ATR (14)
$0.58
Typical daily range, 21.6% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for OKUR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how OKUR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow OKUR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for OKURHow many large options trades hit OKUR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in OKUR in the last 90 days.
From SEC Form 4 filings by OKUR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OKUR is in one of them and how their past OKUR trades turned out.
OnKure Therapeutics is a biopharmaceutical company based in Boulder, Colorado. It develops small molecule drugs that target specific mutated forms of the PI3K alpha protein, a driver of cancer and other diseases, while sparing the normal form of the protein. Its lead candidate, OKI-219, is in Phase 1 clinical trials for patients with advanced breast cancer, and the company is also researching treatments for vascular malformations.